Overview
- The Department of Health and Human Services published the 'Wolves in White Coats' report on Aug. 13, alleging that doctors and hospitals pushed gender-affirming care for minors and profited from it.
- HHS’s claims analysis covers roughly 2015–2025 and reports nearly $50 million billed for puberty blockers under an endocrine-disorder code and about $11 million billed under precocious-puberty codes for older teens, while a watchdog tracked roughly $120 million in related charges since 2019.
- The report accuses some providers of using questionable diagnostic codes—labeling patients with endocrine disorders or precocious puberty—to secure insurance coverage for hormones and surgeries that insurers might otherwise deny.
- It includes detailed detransitioner narratives, including three former patients who say they had irreversible procedures as minors, suffered ongoing health problems, and found little clinical support when seeking reversal or reconstruction.
- HHS links the expansion of these services to 2021 federal policy and professional guidelines that framed refusal to provide care as unlawful discrimination, and the report says the findings have driven renewed media attention and potential regulatory and legal scrutiny though no enforcement actions were specified.